233 related articles for article (PubMed ID: 30384323)
1. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.
Maggio SE; Saunders MA; Nixon K; Prendergast MA; Zheng G; Crooks PA; Dwoskin LP; Bell RL; Bardo MT
Drug Alcohol Depend; 2018 Dec; 193():154-161. PubMed ID: 30384323
[TBL] [Abstract][Full Text] [Related]
2. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
[TBL] [Abstract][Full Text] [Related]
3. Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats.
Chandler CM; Maggio SE; Peng H; Nixon K; Bardo MT
Drug Alcohol Depend; 2020 Jul; 212():107988. PubMed ID: 32387915
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.
Waeiss RA; Knight CP; Hauser SR; Pratt LA; McBride WJ; Rodd ZA
Psychopharmacology (Berl); 2019 Jun; 236(6):1887-1900. PubMed ID: 30758525
[TBL] [Abstract][Full Text] [Related]
5. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
[TBL] [Abstract][Full Text] [Related]
6. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.
Srisontiyakul J; Kastman HE; Krstew EV; Govitrapong P; Lawrence AJ
Neurochem Res; 2016 Dec; 41(12):3206-3214. PubMed ID: 27573375
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
[TBL] [Abstract][Full Text] [Related]
8. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
[TBL] [Abstract][Full Text] [Related]
9. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
[TBL] [Abstract][Full Text] [Related]
10. Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure.
Ginsburg BC; Lamb RJ
Alcohol Clin Exp Res; 2013 Jul; 37(7):1228-33. PubMed ID: 23413834
[TBL] [Abstract][Full Text] [Related]
11. Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.
Funk D; Lo S; Coen K; Lê AD
Behav Brain Res; 2016 Jan; 296():157-162. PubMed ID: 26365457
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats.
Czachowski CL; Froehlich JC; DeLory M
Alcohol Clin Exp Res; 2018 Feb; 42(2):453-460. PubMed ID: 29168193
[TBL] [Abstract][Full Text] [Related]
13. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
[TBL] [Abstract][Full Text] [Related]
14. Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.
Madsen HB; Koghar HS; Pooters T; Massalas JS; Drago J; Lawrence AJ
Addict Biol; 2015 May; 20(3):500-12. PubMed ID: 24750355
[TBL] [Abstract][Full Text] [Related]
15. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
[TBL] [Abstract][Full Text] [Related]
16. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
17. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.
Matzeu A; Terenius L; Martin-Fardon R
Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats.
Berquist MD; Fantegrossi WE
Behav Pharmacol; 2021 Aug; 32(5):382-391. PubMed ID: 33595958
[TBL] [Abstract][Full Text] [Related]
19. Development of an oral operant nicotine/ethanol co-use model in alcohol-preferring (p) rats.
Hauser SR; Katner SN; Deehan GA; Ding ZM; Toalston JE; Scott BJ; Bell RL; McBride WJ; Rodd ZA
Alcohol Clin Exp Res; 2012 Nov; 36(11):1963-72. PubMed ID: 22486609
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
Sabino V; Kwak J; Rice KC; Cottone P
Alcohol Clin Exp Res; 2013 Apr; 37(4):635-43. PubMed ID: 23126554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
